<DOC>
	<DOCNO>NCT01937611</DOCNO>
	<brief_summary>Many study conduct feasibility use dexmedetomidine premedication . However , bradycardia hypotension frequently occur follow premedication dexmedetomidine , either via intramuscular intravenous route . This particularly true use high dose dexmedetomidine : intramuscular dose 2 μg•kg-1 intravenous dose 1 μg•kg-1 elicit mark decrease heart rate mean arterial blood pressure . Subsequent study use high-dose dexmedetomidine reveal potential impact detrimental haemodynamic profile clinical outcome . Most study use high-dose dexmedetomidine predominantly adopt dose-finding study perform Aho colleague , report 2.5 μg•kg-1 dose intramuscular dexmedetomidine comparably sedative anxiolytic 0.08 mg•kg-1 midazolam . However , investigation address clinical effect low-dose dexmedetomidine premedication . Considering modern anaesthesia advance long way towards eliminate routine need deep preoperative sedation . It , therefore , become desirable ass dexmedetomidine effective premedication use moderate sedative dose minimize undesired hemodynamic effect . We set prospective study compare sedative , haemodynamic , adjuvant anaesthetic effect patient 's satisfaction low-dose dexmedetomidine ( 1μg•kg-1 ) midazolam ( 0.03 mg•kg-1 ) , commonly use premedication , use intramuscular injective administration patient undergo suspension laryngoscopic surgery general anaesthesia .</brief_summary>
	<brief_title>Intramuscular Dexmedetomidine Premedication</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Adult patient age 1855 year old , American Society Anaesthesiologists physical status I , schedule elective suspension laryngoscopic surgery benign vocal fold lesion . Patients neurological deficit Pregnancy Imprisonment Morbid obesity ( body mass index ≥ 30 kg•m−2 ) Preoperative heart rate &lt; 45 beats•min−1 Second third degree atrioventricular block Antihypertensive medication αmethyldopa , clonidine α2adrenergic agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>dexmedetomidine</keyword>
	<keyword>intramuscular premedication</keyword>
	<keyword>bradycardiac</keyword>
</DOC>